What Is Prolotherapy, and When Is It the Right Choice?

Prolotherapy is one of the oldest regenerative injection treatments — and still one of the most useful for loose, painful joints and chronic ligament and tendon problems. What it is, what the evidence shows, and how to decide between prolotherapy and PRP.

What is prolotherapy?

Prolotherapy — short for proliferative therapy — is a non-surgical injection treatment for chronic musculoskeletal pain. A small amount of an irritant solution, most commonly dextrose (a medical-grade sugar), is injected at the precise points where ligaments and tendons attach to bone. That brief, controlled irritation prompts the body to mount a localized healing response, drawing in the cells and growth factors that repair and reinforce connective tissue.

Many chronic pains come from connective tissue that has become stretched, weakened, or incompletely healed. Rather than masking that pain, prolotherapy aims to stimulate the body to reinforce the structure itself. It predates platelet-rich plasma by decades and has a substantial body of randomized trial evidence across several musculoskeletal conditions.

How it works

Ligaments and tendons have a poor blood supply, which is why injuries to them can linger for months or years and why they often heal incompletely on their own. When a joint is supported by lax or damaged ligaments, it can move slightly more than it should. That subtle instability irritates surrounding nerves and muscles, producing pain that is hard to pin down and tends to come back.

By introducing a mild irritant exactly where the tissue attaches to bone, prolotherapy triggers a fresh, organized round of the body's natural repair process. Over a series of sessions, the goal is stronger, tighter connective tissue, a more stable joint, and less pain. Treatment is typically delivered as a course of several visits spaced a few weeks apart, guided by ultrasound for accurate placement.

Where the evidence is strongest

Prolotherapy is most useful for pain driven by ligament or tendon laxity and chronic connective-tissue problems. The conditions with the most clinical support include:

• Chronic low back and sacroiliac (SI) joint pain — multiple randomized trials show benefit over placebo, and a 2026 pragmatic RCT found outcomes comparable to epidural steroid injections for lumbar pain with leg symptoms
• Tennis elbow (lateral epicondylitis) — dextrose prolotherapy outperforms corticosteroid at intermediate and long-term follow-up in several RCTs
• Golfer's elbow (medial epicondylitis) — similar evidence pattern to lateral epicondylitis; positive RCT data for dextrose prolotherapy
• Knee osteoarthritis — dextrose prolotherapy injected into the knee joint has shown favorable results in several randomized trials, including sustained improvement at 52 weeks versus saline and exercise
• Joint instability and ligament laxity, including the knee and ankle
• Neck pain related to ligament laxity

Prolotherapy vs. PRP: how to decide

Patients often ask whether they need prolotherapy or platelet-rich plasma (PRP). Both are regenerative injections that work by stimulating the body's own repair response. The difference is in what is injected and how strong a healing signal it sends.

• Prolotherapy uses a dextrose-based solution to provoke a healing response. It is well suited to ligament laxity, joint instability, and broader areas that need reinforcement, and is generally the more economical option.
• PRP uses a concentrated portion of your own blood, delivering a high dose of growth factors directly to a specific injured tendon, joint, or nerve root. It tends to be chosen for more focal, higher-grade tissue damage where a stronger biologic signal is warranted.

In practice the choice depends on the diagnosis, the severity and location of the problem, your goals, and practical factors like cost. The two are not mutually exclusive — some patients do best with prolotherapy for a broad area of instability, others with targeted PRP, and some with a plan that uses each where it fits.

When prolotherapy is the right choice

Prolotherapy tends to be a strong fit when pain is coming from lax or weakened ligaments and tendons, when a joint feels subtly unstable, when conservative care like physical therapy has helped but not resolved the problem, and when you want a non-surgical option that addresses the underlying structure rather than just calming symptoms.

The bottom line

Prolotherapy remains a valuable, evidence-informed option for chronic ligament, tendon, and joint pain — especially where instability and incomplete healing are driving the problem. Whether prolotherapy, PRP, or a combination makes the most sense depends on an accurate diagnosis and a treatment plan matched to it.